...
首页> 外文期刊>Hormone and Metabolic Research >A novel pE311K mutation of thyroid receptor beta gene in resistance to thyroid hormone syndrome, inherited in autosomal recessive trait
【24h】

A novel pE311K mutation of thyroid receptor beta gene in resistance to thyroid hormone syndrome, inherited in autosomal recessive trait

机译:遗传性常染色体隐性遗传的新型pE311K甲状腺受体β基因突变,可抵抗甲状腺激素综合征

获取原文
获取原文并翻译 | 示例
           

摘要

Resistance to thyroid hormone (RTH) syndrome is caused by mutations in THRB gene and is inherited mainly as an autosomal dominant trait with dominant negative effect. Most of up-to-now described RTH cases were heterozygous. We studied a 19-year-old woman presenting severe mental impairment, hyperkinetic behavior, learning disability, hearing loss, tachycardia, goiter, strabismus, nystagmus, and normal stature. The laboratory findings revealed elevated TSH, T3, and T4 serum levels. Her parents were healthy with normal serum level of TSH, fT3, and fT4. Sequence based prediction of a substitution was analyzed by SDM, PolPhen, and SNAP software whereas structural visualizations were performed in UCSF Chimera. We found a novel mutation in THRB gene in position 1216 (G to A transition, codon 311) resulting in novel Glu-311-Lys (p.E311K) substitution, homozygous in proband presenting with severe symptoms of RTH and heterozygous in both of her healthy parents, thus suggesting autosomal recessive mode of inheritance. p.E311K substitution was not found in 50 healthy, unrelated individuals. p.E311K was shown to be deleterious by SDM, PolPhen, and SNAP software. Structural visualizations of mutated protein performed by UCSF Chimera software disclosed a loss of hydrogen bonds between E311, R383, and R429 along with abnormal residue-residue contact between K311 and L377. This is a very rare case of a homozygous mutation in a patient with severe symptoms of RTH and lack of symptoms in both heterozygous parents. Although, computational analyses have provided the evidence that p.E311K substitution may affect THRB function, lack of dominant negative effect typical for THRB mutations could not be explained by structure-based modeling. Further in vitro analysis is required to assess the functional consequences of this substitution.
机译:对甲状腺激素(RTH)综合征的抗性是由THRB基因突变引起的,并且主要作为常染色体显性遗传而遗传,具有显性负效应。到目前为止,大多数描述的RTH病例都是杂合的。我们研究了一名19岁妇女,该妇女表现出严重的精神障碍,运动过度行为,学习障碍,听力下降,心动过速,甲状腺肿,斜视,眼球震颤和身材正常。实验室检查结果显示TSH,T3和T4血清水平升高。她的父母身体健康,血清TSH,fT3和fT4正常。通过SDM,PolPhen和SNAP软件分析了基于序列的取代预测,而在UCSF Chimera中进行了结构可视化。我们在位置1216的THRB基因中发现了一个新突变(G向A过渡,密码子311),导致了新的Glu-311-Lys(p.E311K)取代,先证者纯合子在她两个人中均表现出RTH和杂合子的严重症状健康的父母,因此暗示了常染色体隐性遗传方式。在50个健康,无关的个体中未发现p.E311K替代。 SDM,PolPhen和SNAP软件显示p.E311K有害。通过UCSF Chimera软件进行的突变蛋白的结构可视化显示,E311,R383和R429之间的氢键丢失,以及K311和L377之间的异常残基-残基接触。这是患有RTH的严重症状而父母双方都没有症状的纯合突变的罕见病例。虽然,计算分析提供了p.E311K替代可能影响THRB功能的证据,但基于结构的建模无法解释THRB突变典型缺乏显性负效应的现象。需要进一步的体外分析以评估这种替代的功能后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号